Fondazione IRCCS Istituto Nazionale dei Tumori, Milano: all 172 studies

Page 2 of 2. Open to participants first (50), then studies with results posted, then the rest; newest registration first within each.

• A Study of CaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinomaCompletedNCT03463681Phase 2
• Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study)TerminatedNCT03456401Phase 2
• Impact of Dietary Intervention on Tumor Immunity: the DigesT TrialStatus unknownNCT03454282Not applicable
• Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial)Status unknownNCT03449173Phase 2
• Pembrolizumab in First Line Treatment of Advanced NSCLC Patients With PD-L1 Low Tumors.Status unknownNCT03447678Phase 2
• caBozantinib in cOllectiNg ductS Renal Cell cArcInomaCompletedNCT03354884Phase 2
• Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck CancerStatus unknownNCT03294122
• A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.CompletedNCT03103724Phase 2
• Selective Axillary Lymph Node Dissection Vs Complete Axillary Dissection: A Randomised Clinical Trial to Assess the Prevention of Lymphedema in Breast Cancer TreatmentCompletedNCT03083314Not applicable
• Durvalumab Alone or With Tremelimumab in Refractory Germ Cell TumorsTerminatedNCT03081923Phase 2
• Dietary Intervention and BRCA PenetranceCompletedNCT03066856Not applicable
• Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the BreastCompletedNCT03002766Phase 2
• Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic SyndromeCompletedNCT02960711Phase 3
• HIPEC Using High Intra-abdominal PressureCompletedNCT02949791Phase 2
• Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction CancersStatus unknownNCT02934464Phase 3
• Prevalence of Ocular Disorders in Multiple Myeloma (MM-OO-16)CompletedNCT02917239
• Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC)CompletedNCT02898415
• Cyberknife After Breast Conservative SurgeryStatus unknownNCT02896322Not applicable
• Tertiary Prevention of Head and Neck Cancer With a Dietary InterventionCompletedNCT02869399Not applicable
• Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland CancersCompletedNCT02867852Phase 2
• Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14CompletedNCT02860936Phase 2
• Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14CompletedNCT02857712Phase 2
• Early Lung Cancer Detection in High Risk IndividualsCompletedNCT02837809Not applicable
• The MetNET-2 TrialStatus unknownNCT02823691Early Phase 1
• Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder CarcinomaCompletedNCT02736266Phase 2
• Home Enteral Nutrition in Malnourished Patients With Gastrointestinal CancerCompletedNCT02664974Phase 3
• Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk PatientsCompletedNCT02575859Phase 1/2
• Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor PatientsCompletedNCT02547831
• Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers DiscoveryTerminatedNCT02535351Phase 3
• Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodineCompletedNCT02479347Phase 4
• Panitumumab-based Maintenance in Patients With RAS Wild-type, Metastatic Colorectal Cancer (Valentino)Status unknownNCT02476045Phase 2
• NAC Sparing Mastectomy After Neo-adjuvant ChemotherapyCompletedNCT02471742
• Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer PatientsCompletedNCT02414009Phase 2
• Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular TargetsStatus unknownNCT02353429Phase 2
• Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETsStatus unknownNCT02294006Phase 2
• Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus PaclitaxelStatus unknownNCT02290470Phase 2
• Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell CancerStatus unknownNCT02268747Phase 2
• Molecular Profile of Metastatic Sporadic Medullary Thyroid Cancer Patients and Correlation With VandetanibCompletedNCT02268734
• Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck CancerSuspendedNCT02262221Not applicable
• Phase II Study on Axitinib in Advanced Solitary Fibrous TumorCompletedNCT02261207Phase 2
• Preemptive Treatment With XONRID to Reduce Radiation Induced Dermatitis in Head and Neck Cancer PatientsCompletedNCT02261181Not applicable
• A Randomized Double Blind Controlled Trial Comparing Sugammadex and Neostigmine After Thoracic AnesthesiaTerminatedNCT02256280Phase 4
• Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective StudyActive, not recruitingNCT02247453Not applicable
• Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA TrialCompletedNCT02176369Phase 2
• Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell TumorsCompletedNCT02161692Phase 2
• Second Line Sorafenib After Pazopanib in Patients With RCCTerminatedNCT02122003Phase 2
• Alisertib in Chemotherapy-pretreated Urothelial CancerCompletedNCT02109328Phase 2
• Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable PatientsStatus unknownNCT02099188Phase 2
• Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable PatientsStatus unknownNCT02099175Phase 2
• PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASESCompletedNCT02086656Phase 2
• TARC After alloSCT in Hodgkin's LymphomaCompletedNCT02069639
• Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell CancerCompletedNCT01914900Phase 2
• A Study Comparing ex Vivo MRI Versus Radiography of Breast SpecimensStatus unknownNCT01869335Not applicable
• Whole Body Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) in Multiple MyelomaCompletedNCT01829412Not applicable
• Pazopanib in Advanced and Cisplatin-resistant Germ Cell TumorsCompletedNCT01743482Phase 2
• Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the PenisCompletedNCT01728233Phase 2
• Activity of Sorafenib in Salivary Gland CancerCompletedNCT01703455Phase 2
• Prospective Observational Study on Plerixafor After ChemotherapyCompletedNCT01700608
• Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell LymphomaCompletedNCT01679860Phase 2
• PF-03446962 in Relapsed or Refractory Urothelial CancerCompletedNCT01620970Phase 2
• Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast CancerCompletedNCT01508546Phase 3
• Evaluation of Accelerometer-Based Neuromuscular Monitoring Reliability to Exclude Postoperative Residual ParalysisCompletedNCT01503840Not applicable
• Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the MetastasesStatus unknownNCT01444807Phase 2
• Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through DownstagingCompletedNCT01387503Not applicable
• Colorectal Cancer Detection by Means of Optical FluoroscopyStatus unknownNCT01286064Not applicable
• Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the BladderStatus unknownNCT01222676Phase 2
• A Questionnaire to Assess the Quality of Life of Rectal Cancer Patients With or Without StomaCompletedNCT01181557
• High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line TherapyStatus unknownNCT01172912Phase 2
• Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to TreatmentCompletedNCT01031875Phase 2
• Diagnosis of Rectal Cancer by Electromagnetic DeviceCompletedNCT00963794Not applicable
• Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular CarcinomaCompletedNCT00910572Phase 2
• Chemotherapy Plus Surgery in Treating Women With Breast CancerCompletedNCT00003013Phase 3

← Fondazione IRCCS Istituto Nazionale dei Tumori, Milano overview and focus areas